TP53 and cancer: Activation of BIK through transcriptional pathways (dependent on factors such as E2f and p53 or by epigenetic regulating mechanisms) was described following treatment with anti-cancer drugs [46], and upregulation of BIK is considered as an interventional approach to treat some tumors [47].